10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing
24 April 2024 - 6:42AM
10X Capital Venture Acquisition Corp. III (NYSE American: VCXB)
(“10X III”), announced today that New York Stock Exchange
Regulation, Inc., by letter dated April 17, 2024 (the “Notice”),
notified 10X III that it was not in compliance with the NYSE
American LLC’s (“NYSE American”) continued listing standards
because 10X III did not timely file its Annual Report on Form 10-K
for the fiscal year ended December 31, 2023 (the “Annual Report”),
which was due on April 16, 2024. 10X III was unable to timely file
the Annual Report because 10X III’s independent registered public
accounting firm required additional time to complete its review of
10X III’s financial statements for the year ended December 31,
2023.
The Notice provides that 10X III has a period of six months from
the due date of the Annual Report (the “Cure Period”) to file such
report and that 10X III can regain compliance with the NYSE
American’s continued listing standards at any time before that date
by filing the Annual Report with the Securities and Exchange
Commission (“SEC”) and any other subsequent reports that are
required to be filed during the cure period. 10X III intends to
cure its non-compliance with the continued listing standards of the
NYSE American by filing the Annual Report within the Cure
Period.
About 10X Capital Venture Acquisition
Corp. III
10X Capital Venture Acquisition Corp. III (NYSE American:
VCXB.U, VCXB, VCXB WS) is a special purpose acquisition company
sponsored by 10X Capital, focused on identifying high growth
businesses domestically and abroad and bringing them to the public
markets. For more information
visit https://www.10xspac.com/spaciii.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. We intend such forward-looking statements to be covered by
the safe harbor provisions for forward-looking statements contained
in Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements generally are accompanied by words such
as “will,” “expect,” “anticipated,” “estimated,” “believe,”
“intend,” “plan,” “projection,” “outlook” or words of similar
meaning. All statements contained in this press release other than
statements of historical fact should be considered forward-looking
statements, including without limitation the timing for when 10X
III will file its Annual Report. These forward-looking statements
are not guarantees of future performance, conditions or results,
and involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
10X III’s control, that could cause actual results or outcomes to
differ materially from those discussed in the forward-looking
statements, including the risks, uncertainties, and assumptions
described in 10X III’s Annual Report on Form 10-K for the year
ended December 31, 2022, filed with the SEC, as updated by 10X
III’s other filings it files with or furnishes to the SEC. Any
forward-looking statements made herein speak only as of the date of
this press release or to conform these statements to actual results
or revised expectations.
Contactir@10xcapital.com
10X Capital Venture Acqu... (AMEX:VCXB)
Historical Stock Chart
From Aug 2024 to Sep 2024
10X Capital Venture Acqu... (AMEX:VCXB)
Historical Stock Chart
From Sep 2023 to Sep 2024